Recursion Pharmaceuticals, Inc. (BMV:RXRX)
89.00
+5.01 (5.96%)
At close: Dec 4, 2025
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of 44.67 billion as of December 5, 2025. Its market cap has increased by 25.80% in one year.
Market Cap
44.67B
Enterprise Value
34.16B
Revenue
801.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
89.00
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from 101.17B to 44.67B, a decrease of -55.85%. That is a compound annual growth rate of -16.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 46.77B | -15.81% |
| Dec 31, 2024 | 55.56B | 53.86% |
| Dec 29, 2023 | 36.11B | 26.67% |
| Dec 30, 2022 | 28.51B | -51.96% |
| Dec 31, 2021 | 59.35B | -41.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wal-Mart de México | 1,034.78B |
| Grupo Financiero Banorte | 487.26B |
| Arca Continental | 317.94B |
| Industrias Peñoles | 315.30B |
| GMéxico Transportes | 143.33B |
| FIBRA Prologis | 119.35B |
| Promotora y Operadora de Infraestructura, S. A. B. de C. V. | 105.57B |
| Fibra UNO | 101.86B |